{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:08:07Z","timestamp":1788782887132,"version":"build-2803163510"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010523","name":"Centre for Addiction and Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010523","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.schres.2026.07.013","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:32:29Z","timestamp":1784651549000},"page":"175-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pharmacogenomics of antipsychotic-induced weight gain: A systematic review"],"prefix":"10.1016","volume":"296","author":[{"given":"Martin","family":"Kronenbuerger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emytis","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Magarbeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar S.M.","family":"Elsheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Gorbovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement C.","family":"Zai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fleischmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwyneth","family":"Zai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kloiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun K.","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2026.07.013_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.595219","article-title":"Pharmacogenetics guidelines: Overview and comparison of the DPWG, CPIC, CPNDS, and RNPGx guidelines","volume":"11","author":"Abdullah-Koolmees","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.schres.2026.07.013_bb0010","first-page":"1","article-title":"Role of D2 receptor (\u2212141 C Ins\/Del) genetic polymorphism on olanzapine-induced adverse drug reaction in schizophrenic patients","volume":"71","author":"Ali","year":"2024","journal-title":"Pharmacia"},{"key":"10.1016\/j.schres.2026.07.013_bb0015","first-page":"111","article-title":"Associations between the LEP -2548G\/A promoter and baseline weight and between LEPR Gln223Arg and Lys656Asn variants and change in BMI Z scores in Arab children and adolescents treated with risperidone","volume":"4","author":"Almandil","year":"2018","journal-title":"Mol. Neuropsychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0020","article-title":"Genetic predisposition and antipsychotic treatment effect on metabolic syndrome in schizophrenia: A ten-year follow-up study using the Estonian Biobank","volume":"41","author":"Alver","year":"2024","journal-title":"Lancet Reg. Health Eur."},{"key":"10.1016\/j.schres.2026.07.013_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/jgc4.1884","article-title":"Race, ethnicity, and ancestry reporting in genetic counseling research: a focused mapping review and synthesis","volume":"34","author":"Arpone","year":"2025","journal-title":"J. Genet. Couns."},{"key":"10.1016\/j.schres.2026.07.013_bb0030","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.mp.4002009","article-title":"Pharmacogenetics and pharmacogenomics of schizophrenia: A review of last decade of research","volume":"12","author":"Arranz","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15082134","article-title":"Multilocus genetic profile reflecting low dopaminergic signaling is directly associated with obesity and cardiometabolic disorders due to antipsychotic treatment","volume":"15","author":"Arrue","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.schres.2026.07.013_bb0040","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1210\/jc.2018-00258","article-title":"Melanocortin 4 receptor pathway dysfunction in obesity: Patient stratification aimed at MC4R agonist treatment","volume":"103","author":"Ayers","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.schres.2026.07.013_bb0045","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/acps.13734","article-title":"Glucagon-like peptide agonists for weight management in antipsychotic-induced weight gain: A systematic review and meta-analysis","volume":"150","author":"Bak","year":"2024","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2026.07.013_bb0050","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-18-0596","article-title":"The melanocortin pathway and control of appetite-progress and therapeutic implications","volume":"241","author":"Baldini","year":"2019","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.schres.2026.07.013_bb0055","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.tem.2014.07.004","article-title":"Molecular pathophysiology of metabolic effects of antipsychotic medications","volume":"25","author":"Ballon","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.schres.2026.07.013_bb0060","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/s41467-019-09152-7","article-title":"Sterol regulatory element binding protein 1 couples mechanical cues and lipid metabolism","volume":"10","author":"Bertolio","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.schres.2026.07.013_bb0065","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/ahg.70007","article-title":"Power and limitations of inferring genetic ancestry","volume":"89","author":"Bird","year":"2025","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.schres.2026.07.013_bb0070","first-page":"1123","article-title":"Search for possible associations of FTO gene polymorphic variants with metabolic syndrome, obesity and body mass index in schizophrenia patients","volume":"14","author":"Boiko","year":"2021","journal-title":"Pharmacogenomics Pers. Med."},{"key":"10.1016\/j.schres.2026.07.013_bb0075","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1176\/appi.ajp.2018.18070881","article-title":"No support for historical candidate gene or candidate gene-by-interaction hypotheses for major depression across multiple large samples","volume":"176","author":"Border","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0080","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/mp.2010.38","article-title":"Poor replication of candidate genes for major depressive disorder using genome-wide association data","volume":"16","author":"Bosker","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.mgene.2015.09.004","article-title":"Genetic and epigenetic variants in the MTHFR gene are not associated with non-Hodgkin lymphoma","volume":"6","author":"Bradshaw","year":"2015","journal-title":"Meta Gene"},{"key":"10.1016\/j.schres.2026.07.013_bb0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/ije\/dyn147","article-title":"Size matters: Just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology","volume":"38","author":"Burton","year":"2009","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.schres.2026.07.013_bb0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jecm.2012.01.007","article-title":"Metabolic and cardiovascular adverse effects associated with treatment with antipsychotic drugs","volume":"4","author":"Chang","year":"2012","journal-title":"J. Exp. Clin. Med."},{"key":"10.1016\/j.schres.2026.07.013_bb0100","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2217\/pgs-2021-0012","article-title":"Pharmacogenomics variants are associated with BMI differences between individuals with bipolar and other psychiatric disorders","volume":"22","author":"Charalampidi","year":"2021","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.schres.2026.07.013_bb0105","article-title":"Associations of genetic variants of methylenetetrahydrofolate reductase and serum folate levels with metabolic parameters in patients with schizophrenia","volume":"18","author":"Chen","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.schres.2026.07.013_bb0110","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/sim.6787","article-title":"Sample size considerations for the external validation of a multivariable prognostic model: A resampling study","volume":"35","author":"Collins","year":"2016","journal-title":"Stat. Med."},{"key":"10.1016\/j.schres.2026.07.013_bb0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/FPC.0000000000000390","article-title":"Enriched developmental biology molecular pathways impact on antipsychotics-induced weight gain","volume":"30","author":"Corfitsen","year":"2020","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.schres.2026.07.013_bb0120","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1017\/neu.2019.41","article-title":"Molecular pathway analysis associates alterations in obesity-related genes and antipsychotic-induced weight gain","volume":"32","author":"Corfitsen","year":"2020","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.schres.2026.07.013_bb0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1749-6632.2008.03995.x","article-title":"SNAP-25 in neuropsychiatric disorders","volume":"1152","author":"Corradini","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.schres.2026.07.013_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41537-019-0075-y","article-title":"Altered gene expression in antipsychotic-induced weight gain","volume":"5","author":"Crespo-Facorro","year":"2019","journal-title":"NPJ Schizophr."},{"key":"10.1016\/j.schres.2026.07.013_bb0135","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1017\/S1461145713000849","article-title":"MC4R rs489693: A clinical risk factor for second generation antipsychotic-related weight gain?","volume":"16","author":"Czerwensky","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2026.07.013_bb0140","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2147\/NDT.S113099","article-title":"Antipsychotic-associated weight gain: management strategies and impact on treatment adherence","volume":"13","author":"Dayabandara","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.schres.2026.07.013_bb0145","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4038\/cmj.v64i2.8889","article-title":"Genetic association between antipsychotic induced weight gain and FTO gene in a Sri Lankan population","volume":"64","author":"Silva","year":"2019","journal-title":"Ceylon Med. J."},{"key":"10.1016\/j.schres.2026.07.013_bb0150","series-title":"Genetic Epidemiology: Methods and Protocols","first-page":"37","article-title":"Genome-wide association studies","volume":"1793","author":"Dehghan","year":"2018"},{"key":"10.1016\/j.schres.2026.07.013_bb0155","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-019-0792-0","article-title":"Psychotropic drug-induced genetic-epigenetic modulation of CRTC1 gene is associated with early weight gain in a prospective study of psychiatric patients","volume":"11","author":"Delacr\u00e9taz","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.schres.2026.07.013_bb0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/schbul\/sbs139","article-title":"Epigenetic studies of schizophrenia: Progress, predicaments, and promises for the future","volume":"39","author":"Dempster","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.07.013_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020222","article-title":"Association of a single-nucleotide variant rs11100494 of the NPY5R gene with antipsychotic-induced metabolic disorders","volume":"14","author":"Dobrodeeva","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.schres.2026.07.013_bb0170","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.peptides.2010.07.020","article-title":"Insulin-induced gene: A new regulator in lipid metabolism","volume":"31","author":"Dong","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.schres.2026.07.013_bb0175","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1007\/s11427-013-4557-2","article-title":"Transcriptomics: Advances and approaches","volume":"56","author":"Dong","year":"2013","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.schres.2026.07.013_bb0180","doi-asserted-by":"crossref","first-page":"11765","DOI":"10.1074\/jbc.M109.067447","article-title":"Characterization of the human insulin-induced gene 2 (INSIG2) promoter","volume":"285","author":"Fern\u00e1ndez-Alvarez","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.schres.2026.07.013_bb0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ebmental-2021-300291","article-title":"Metformin in the management of antipsychotic-induced weight gain in adults with psychosis: Development of the first evidence-based guideline using GRADE methodology","volume":"25","author":"Fitzgerald","year":"2022","journal-title":"Evid. Based Ment. Health"},{"key":"10.1016\/j.schres.2026.07.013_bb0190","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpsychires.2023.11.038","article-title":"Association of clinical parameters and polygenic risk scores for body mass index, schizophrenia, and diabetes with antipsychotic-induced weight gain","volume":"169","author":"Franz","year":"2024","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2026.07.013_bb0195","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2025.2332","article-title":"Semaglutide treatment of antipsychotic-treated patients with schizophrenia, prediabetes, and obesity","author":"Ganeshalingam","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0200","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/0269881120903462","article-title":"Association study of candidate genes with obesity and metabolic traits in antipsychotic-treated patients with first-episode psychosis over a 2-year period","volume":"34","author":"Gass\u00f3","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.07.013_bb0205","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2710.2009.01084.x","article-title":"Body weight gain induced by atypical antipsychotics: An extension of the monozygotic twin and sib pair study","volume":"35","author":"Gebhardt","year":"2010","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.schres.2026.07.013_bb0210","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.schres.2019.09.015","article-title":"Relationship of SNAP25 variants with schizophrenia and antipsychotic-induced weight change in large-scale schizophrenia patients","volume":"215","author":"Guan","year":"2020","journal-title":"Schizophr Res."},{"key":"10.1016\/j.schres.2026.07.013_bb0215","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/0269881110389214","article-title":"Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs","volume":"25","author":"Hasnain","year":"2011","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2026.07.013_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/hup.70035","article-title":"Developing a Polygenic Risk Score for Weight Gain in People Treated for Psychosis-Application in a Real-World Setting","volume":"41","author":"Heald","year":"2026","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.07.013_bb0225","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.genhosppsych.2024.06.003","article-title":"Pharmacological interventions for antipsychotic-induced weight gain in schizophrenia: A network meta-analysis","volume":"90","author":"Hegde","year":"2024","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0230","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/cpt.2339","article-title":"Pharmacogenetics-guided advances in antipsychotic treatment","volume":"110","author":"Islam","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.schres.2026.07.013_bb0235","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1210\/en.2011-1822","article-title":"Effects of leptin and melanocortin signaling interactions on pubertal development and reproduction","volume":"153","author":"Israel","year":"2012","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.schres.2026.07.013_bb0240","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1089\/cap.2020.0058","article-title":"CYP2D6 Phenotype Influences Aripiprazole Tolerability in Pediatric Patients with Mood Disorders","volume":"31","author":"Jallaq","year":"2021","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"S2","key":"10.1016\/j.schres.2026.07.013_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/j.1550-8528.1995.tb00471.x","article-title":"Who are the weight maintainors?","volume":"3","author":"Jeor","year":"1995","journal-title":"Obes. Res."},{"issue":"1","key":"10.1016\/j.schres.2026.07.013_bb0250","doi-asserted-by":"crossref","first-page":"15304","DOI":"10.1038\/s41598-021-94700-9","article-title":"Association of CNR1 and INSIG2 polymorphisms with antipsychotics-induced weight gain: a prospective nested case-control study","volume":"11","author":"Jimeno","year":"2021","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.schres.2026.07.013_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12101728","article-title":"Is the CYP2D6 genotype associated with antipsychotic-induced weight gain?","volume":"12","author":"J\u00fcrgens","year":"2022","journal-title":"J. Pers. Med."},{"issue":"1","key":"10.1016\/j.schres.2026.07.013_bb0260","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1089\/cap.2023.0046","article-title":"Influence of CYP2D6 Metabolizer Status on Risperidone and Paliperidone Tolerability in Children and Adolescents","volume":"34","author":"Kanu","year":"2024","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.schres.2026.07.013_bb0265","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/jamia\/ocab251","article-title":"Inference-Based Correction of Multi-Site Height and Weight Measurement Data in the All of Us Research Program","volume":"29","author":"Khan","year":"2022","journal-title":"Journal of the American Medical Informatics Association: JAMIA"},{"issue":"2","key":"10.1016\/j.schres.2026.07.013_bb0270","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s12325-020-01566-w","article-title":"Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics","volume":"38","author":"Koller","year":"2021","journal-title":"Adv. Ther."},{"issue":"1","key":"10.1016\/j.schres.2026.07.013_bb0275","doi-asserted-by":"crossref","DOI":"10.1186\/s41232-021-00172-9","article-title":"Statistical Genetics and Polygenic Risk Score for Precision Medicine","volume":"41","author":"Konuma","year":"2021","journal-title":"Inflammation and Regeneration"},{"issue":"1","key":"10.1016\/j.schres.2026.07.013_bb0280","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.xphs.2020.10.027","article-title":"Correlation of Body Weight and Composition with Hepatic Activities of Cytochrome P450 Enzymes","volume":"110","author":"Krogstad","year":"2021","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.schres.2026.07.013_bb0285","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.jcp.0000203196.65710.2b","article-title":"Risperidone-Related Weight Gain: Genetic and Nongenetic Predictors","volume":"26","author":"Lane","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.schres.2026.07.013_bb0290","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/oby.20162","article-title":"Genetic association of adrenergic receptor alpha 2A with obesity and type 2 diabetes","volume":"21","author":"L\u00e5ngberg","year":"2013","journal-title":"Obesity (Silver Spring, Md.)"},{"issue":"8","key":"10.1016\/j.schres.2026.07.013_bb0295","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1177\/02698811251337374","article-title":"Centrally-Acting Opioid Receptor Antagonists as a Treatment for Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis of Clinical Trial Data","volume":"39","author":"Lee","year":"2025","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"6","key":"10.1016\/j.schres.2026.07.013_bb0300","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1586\/14737159.2016.1171714","article-title":"The potential of genetic and gene expression analysis in the diagnosis of neuropsychiatric disorders","volume":"16","author":"Leemput","year":"2016","journal-title":"Expert. Rev. Mol. Diagn."},{"issue":"3","key":"10.1016\/j.schres.2026.07.013_bb0305","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/mp.2011.109","article-title":"Pharmacogenetics of Antipsychotic-Induced Weight Gain: Review and Clinical Implications","volume":"17","author":"Lett","year":"2012","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2026.07.013_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/ani10081317","article-title":"Regulatory roles of SREBF1 and SREBF2 in lipid metabolism and deposition in two Chinese representative fat-tailed sheep breeds","volume":"10","author":"Liang","year":"2020","journal-title":"Animals: An Open Access Journal from MDPI"},{"key":"10.1016\/j.schres.2026.07.013_bb0315","first-page":"617","article-title":"C677T polymorphism in the MTHFR gene is associated with risperidone-induced weight gain in schizophrenia","volume":"11","author":"Liao","year":"2020","journal-title":"Front. Psychol."},{"issue":"6","key":"10.1016\/j.schres.2026.07.013_bb0320","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1038\/s41380-024-02447-2","article-title":"Genome-wide association study implicates lipid pathway dysfunction in antipsychotic-induced weight gain: multi-ancestry validation","volume":"29","author":"Liao","year":"2024","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.07.013_bb0325","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41398-021-01585-3","article-title":"The Association between BDNF Levels and Risperidone-Induced Weight Gain Is Dependent on the BDNF Val66Met Polymorphism in Antipsychotic-Naive First Episode Schizophrenia Patients: A 12-Week Prospective Study","volume":"11","author":"Liu","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0330","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.schres.2026.02.011","article-title":"MC4R methylation and antipsychotic-related metabolic changes in early psychosis: findings from two prospective cohorts","volume":"291","author":"Loureiro","year":"2026","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2026.07.013_bb0335","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-020-03034-9","article-title":"Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone","volume":"21","author":"Lu","year":"2021","journal-title":"BMC Psychiatry"},{"issue":"115226","key":"10.1016\/j.schres.2026.07.013_bb0340","article-title":"The positive association between antipsychotic-induced weight gain and therapeutic response: new biotypes of schizophrenia","volume":"324","author":"Lu","year":"2023","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.schres.2026.07.013_bb0345","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s12264-018-0323-6","article-title":"Pharmacogenetic correlates of antipsychotic-induced weight gain in the Chinese population","volume":"35","author":"Luo","year":"2019","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.schres.2026.07.013_bb0350","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00702-018-1921-1","article-title":"Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain","volume":"126","author":"Maciukiewicz","year":"2019","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.schres.2026.07.013_bb0355","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.schres.2019.07.022","article-title":"Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans","volume":"212","author":"Maciukiewicz","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.07.013_bb0360","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000445802","article-title":"Genetics of common antipsychotic-induced adverse effects","volume":"2","author":"MacNeil","year":"2016","journal-title":"Complex Psychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0365","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1001\/archgenpsychiatry.2012.191","article-title":"Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain","volume":"69","author":"Malhotra","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0370","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.729474","article-title":"Identification of EP300 as a key gene involved in antipsychotic-induced metabolic dysregulation based on integrative bioinformatics analysis of multi-tissue gene expression data","volume":"12","author":"Mart\u00ednez-Pinte\u00f1o","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.schres.2026.07.013_bb0375","first-page":"263","article-title":"Basic review of the cytochrome P450 system","volume":"4","author":"McDonnell","year":"2013","journal-title":"J. Adv. Pract. Oncol."},{"key":"10.1016\/j.schres.2026.07.013_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/ph18070941","article-title":"The role of GST gene polymorphic variants in antipsychotic-induced metabolic disorders in schizophrenia: a pilot study","volume":"18","author":"Mednova","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.schres.2026.07.013_bb0385","doi-asserted-by":"crossref","first-page":"21283","DOI":"10.1038\/s41598-020-78474-0","article-title":"Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia","volume":"10","author":"Menus","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.schres.2026.07.013_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/nu10111600","article-title":"Fat mass and obesity associated (FTO) gene and hepatic glucose and lipid metabolism","volume":"10","author":"Mizuno","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.schres.2026.07.013_bb0395","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.phrs.2003.05.001","article-title":"Pharmacogenetics of antipsychotic-induced weight gain","volume":"49","author":"M\u00fcller","year":"2004","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.schres.2026.07.013_bb0400","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/YCO.0b013e32835dc9da","article-title":"The pharmacogenetics of antipsychotic-induced adverse events","volume":"26","author":"M\u00fcller","year":"2013","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0405","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.drugalcdep.2013.03.023","article-title":"Improving the reliability and reporting of genetic association studies","volume":"132","author":"Munaf\u00f2","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.schres.2026.07.013_bb0410","article-title":"Selected SNPs in the BDNF and DRD2 genes and their associations with antipsychotic-induced weight gain in a Sri Lankan cohort","volume":"46","author":"Muneeswaran","year":"2025","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.schres.2026.07.013_bb0415","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2023.9","article-title":"Polygenic risk scores enhance prediction of body mass index increase in individuals with a first episode of psychosis","volume":"66","author":"Muntan\u00e9","year":"2023","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2023.102578","article-title":"Association between PLA2 gene polymorphisms and treatment response to antipsychotic medications: A study of antipsychotic-na\u00efve first-episode psychosis patients and nonadherent chronic psychosis patients","volume":"194","author":"Nadalin","year":"2023","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.schres.2026.07.013_bb0425","first-page":"R1053","article-title":"The lighter side of BDNF","volume":"300","author":"Noble","year":"2011","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.schres.2026.07.013_bb0430","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2013.26","article-title":"Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP Autism Network risperidone studies","volume":"3","author":"Nurmi","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0435","article-title":"Polygenic overlap with body-mass index improves prediction of treatment-resistant schizophrenia","volume":"325","author":"O\u2019Connell","year":"2023","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2026.07.013_bb0440","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.schres.2025.03.005","article-title":"Dopamine receptor D2 (DRD2) TaqIA gene polymorphism and acute risperidone-induced changes in body weight, plasma glucose and lipid profile","volume":"277","author":"Olasore","year":"2025","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.07.013_bb0445","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jpsychires.2019.04.017","article-title":"Getting to precision psychopharmacology: Combining clinical and genetic information to predict fat gain from aripiprazole","volume":"114","author":"Oughli","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2026.07.013_bb0450","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11030181","article-title":"Genetic polymorphisms of 5-HT receptors and antipsychotic-induced metabolic dysfunction in patients with schizophrenia","volume":"11","author":"Paderina","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.schres.2026.07.013_bb0455","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst. Rev."},{"key":"10.1016\/j.schres.2026.07.013_bb0460","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/acps.13066","article-title":"Antipsychotic use and risk of life-threatening medical events: Umbrella review of observational studies","volume":"140","author":"Papola","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2026.07.013_bb0465","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jama.299.11.1335","article-title":"How to interpret a genome-wide association study","volume":"299","author":"Pearson","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.schres.2026.07.013_bb0470","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/schbul\/sbae173","article-title":"The optimal dosage and duration of metformin for prevention and treatment of antipsychotic-induced weight gain: An updated systematic review and meta-analysis","volume":"51","author":"Peng","year":"2025","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.07.013_bb0475","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12024-010-9188-3","article-title":"Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects","volume":"7","author":"Pilgrim","year":"2011","journal-title":"Forensic Sci. Med. Pathol."},{"key":"10.1016\/j.schres.2026.07.013_bb0480","doi-asserted-by":"crossref","DOI":"10.1007\/s12687-026-00880-0","article-title":"Integrating genetic ancestry into clinical care: Accuracy, utility, and stakeholder views","volume":"17","author":"Prettyman","year":"2026","journal-title":"J Community Genet."},{"key":"10.1016\/j.schres.2026.07.013_bb0485","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/0706743717719898","article-title":"Physical health and drug safety in individuals with schizophrenia","volume":"62","author":"Pringsheim","year":"2017","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.schres.2026.07.013_bb0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2013.06.035","article-title":"CYP450 pharmacogenetic treatment strategies for antipsychotics: A review of the evidence","volume":"149","author":"Ravyn","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.07.013_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215477","article-title":"Sex differences in gene expression related to antipsychotic induced weight gain","volume":"14","author":"Sainz","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2026.07.013_bb0500","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40291-013-0028-5","article-title":"Applications of CYP450 testing in the clinical setting","volume":"17","author":"Samer","year":"2013","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.schres.2026.07.013_bb0505","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/jamapsychiatry.2025.3639","article-title":"Semaglutide and early-stage metabolic abnormalities in individuals with schizophrenia spectrum disorders","volume":"83","author":"Sass","year":"2026","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0510","first-page":"899","article-title":"Genetic association of the rs17782313 polymorphism with antipsychotic-induced weight gain","volume":"240","author":"Schreyer","year":"2023","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2026.07.013_bb0515","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2022.05.021","article-title":"Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohort","volume":"244","author":"Segura","year":"2022","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.07.013_bb0520","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s43141-021-00147-w","article-title":"Correlation of methylation status in MTHFR promoter region with recurrent pregnancy loss","volume":"19","author":"Shaker","year":"2021","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"10.1016\/j.schres.2026.07.013_bb0525","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11920-014-0473-9","article-title":"Antipsychotic induced weight gain: Genetics, epigenetics, and biomarkers reviewed","volume":"16","author":"Shams","year":"2014","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.schres.2026.07.013_bb0530","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1177\/0269881115613519","article-title":"Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: a double blind, randomized, placebo controlled study","volume":"29","author":"Silva","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.07.013_bb0535","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-016-1049-5","article-title":"Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis","volume":"16","author":"Silva","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0540","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S2215-0366(25)00129-4","article-title":"Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): A phase 2, multi-centre, participant and investigator-blinded, randomised controlled trial in Australia","volume":"12","author":"Siskind","year":"2025","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0545","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1038\/s41380-023-02082-3","article-title":"Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis","volume":"28","author":"Sjaarda","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0550","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12863-015-0211-2","article-title":"Assessing the quality of published genetic association studies in meta-analyses: The Quality of Genetic Studies (Q-Genie) tool","volume":"16","author":"Sohani","year":"2015","journal-title":"BMC Genet."},{"key":"10.1016\/j.schres.2026.07.013_bb0555","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1080\/14740338.2024.2396396","article-title":"Risk factors, prevention and treatment of weight gain associated with the use of antidepressants and antipsychotics: A state-of-the-art clinical review","volume":"23","author":"Solmi","year":"2024","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.schres.2026.07.013_bb0560","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00406-025-02062-4","article-title":"Genetic predisposition to unwanted side effects under antidepressants and antipsychotics: A molecular-genetic study of 902 patients over 6 weeks","volume":"276","author":"Stassen","year":"2026","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2026.07.013_bb0565","series-title":"Dopamine-based reward circuitry responsivity, genetics, and overeating, in: Current Topics in Behavioral Neurosciences","author":"Stice","year":"2010"},{"key":"10.1016\/j.schres.2026.07.013_bb0570","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s11920-023-01458-0","article-title":"Antipsychotic-induced weight gain in severe mental illness: Risk factors and special considerations","volume":"25","author":"Stogios","year":"2023","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.schres.2026.07.013_bb0575","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/wps.20567","article-title":"Management of common adverse effects of antipsychotic medications","volume":"17","author":"Stroup","year":"2018","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0580","article-title":"Association of MTHFR C677T polymorphism with antipsychotic-induced change of weight and metabolism index","volume":"12","author":"Su","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.schres.2026.07.013_bb0585","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41576-019-0127-1","article-title":"Benefits and limitations of genome-wide association studies","volume":"20","author":"Tam","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.schres.2026.07.013_bb0590","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/0269881120907972","article-title":"A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort)","volume":"34","author":"ter Hark","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.07.013_bb0595","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00041444-200512000-00011","article-title":"Clozapine-induced weight gain: A study in monozygotic twins and same-sex sib pairs","volume":"15","author":"Theisen","year":"2005","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.schres.2026.07.013_bb0600","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/YCO.0000000000000952","article-title":"GLP-1 receptor agonists and weight loss in schizophrenia \u2013 past, present, and future","volume":"37","author":"Trott","year":"2024","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.565074","article-title":"Risperidone-induced obesity in children and adolescents with autism spectrum disorder: Genetic and clinical risk factors","volume":"11","author":"Vanwong","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.schres.2026.07.013_bb0610","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/pds.5224","article-title":"Effect of 5-HT2C receptor gene polymorphism (HTR2C\u2212759C\/T) on metabolic adverse effects in Thai psychiatric patients treated with risperidone","volume":"30","author":"Vanwong","year":"2021","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.schres.2026.07.013_bb0615","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11100943","article-title":"Associations of the SREBF2 gene and INSIG2 polymorphisms with obesity and dyslipidemia in Thai psychotic disorder patients treated with risperidone","volume":"11","author":"Vanwong","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.schres.2026.07.013_bb0620","doi-asserted-by":"crossref","first-page":"A160","DOI":"10.1289\/ehp.114-a160","article-title":"Epigenetics: the science of change","volume":"114","author":"Weinhold","year":"2006","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.schres.2026.07.013_bb0625","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/dc24-1678","article-title":"Efficacy of GLP-1 receptor agonists on weight loss, BMI, and waist circumference for patients with obesity or overweight: A systematic review, meta-analysis, and meta-regression of 47 randomized controlled trials","volume":"48","author":"Wong","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.schres.2026.07.013_bb0630","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/jamapsychiatry.2020.3049","article-title":"From basic science to clinical application of polygenic risk scores: a primer","volume":"78","author":"Wray","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0635","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nrn.2016.24","article-title":"Neurotrophic factor control of satiety and body weight","volume":"17","author":"Xu","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.schres.2026.07.013_bb0640","article-title":"Effects of CYP2D6 gene polymorphism on plasma concentration and therapeutic effect of olanzapine","volume":"10","author":"Yang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.schres.2026.07.013_bb0645","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.694204","article-title":"Central 5-HTR2C in the control of metabolic homeostasis","volume":"12","author":"Yao","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.schres.2026.07.013_bb0650","doi-asserted-by":"crossref","first-page":"189","DOI":"10.12793\/tcp.2020.28.e18","article-title":"Pharmacogenomic information from CPIC and DPWG guidelines and its application on drug labels","volume":"28","author":"Yoon","year":"2020","journal-title":"Transl. Clin. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2026.07.013_bb0655","first-page":"1","article-title":"Pharmacogenetics of antipsychotic drug treatment: update and clinical implications","volume":"5","author":"Yoshida","year":"2020","journal-title":"Mol. Neuropsychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109952","article-title":"Association between the -2548G\/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysis","volume":"102","author":"Yoshida","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0665","first-page":"119","article-title":"Polygenic risk scores analyses of psychiatric and metabolic traits with antipsychotic-induced weight gain in schizophrenia: An exploratory study","volume":"23","author":"Yoshida","year":"2023","journal-title":"Pharm. J."},{"key":"10.1016\/j.schres.2026.07.013_bb0670","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/schbul\/sbv179","article-title":"Genome-wide association study suggested the PTPRD polymorphisms were associated with weight gain effects of atypical antipsychotic medications","volume":"42","author":"Yu","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.07.013_bb0675","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/YCO.0000000000000417","article-title":"New findings in pharmacogenetics of schizophrenia","volume":"31","author":"Zai","year":"2018","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.schres.2026.07.013_bb0680","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/schbul\/sbw058","article-title":"Pharmacogenetic associations of antipsychotic drug-related weight gain: A systematic review and meta-analysis","volume":"42","author":"Zhang","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.07.013_bb0685","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s11427-018-9489-x","article-title":"Testing the role of genetic variation of the MC4R gene in Chinese population in antipsychotic-induced metabolic disturbance","volume":"62","author":"Zhang","year":"2019","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.schres.2026.07.013_bb0690","doi-asserted-by":"crossref","first-page":"420","DOI":"10.7150\/ijbs.3.420","article-title":"Candidate gene identification approach: Progress and challenges","volume":"3","author":"Zhu","year":"2007","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.schres.2026.07.013_bb0695","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01393","article-title":"Topiramate and metformin are effective add-on treatments in controlling antipsychotic-induced weight gain: a systematic review and network meta-analysis","volume":"9","author":"Zhuo","year":"2018","journal-title":"Front. Pharmacol."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426002215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426002215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:17:25Z","timestamp":1788779845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426002215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":139,"alternative-id":["S0920996426002215"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.07.013","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacogenomics of antipsychotic-induced weight gain: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}